Z-1100-2020 Class III Terminated

Recalled by Randox Laboratories Ltd. — Crumlin (North), N/A

FDA device recall Z-1100-2020 was initiated by Randox Laboratories Ltd. on Dec 13, 2019 and is designated Class III. Reason for recall: A transcription error has occurred for the Randox Lipase colorimetric value in Liquid Clinical Chemistry Control lot 1021 UE. The target and range are listed as 50 U/L (40 - 60) and should be 72U/L… The recall status is terminated (terminated Oct 2, 2020). Affected quantity: 2.

Recall details

Product Type
Devices
Report Date
Feb 12, 2020
Initiation Date
Dec 13, 2019
Termination Date
Oct 2, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2

Product description

Liquid Clinical Chemistry Control, Catalogue Number: LAE4217, Size: 12 x 5 ml

Reason for recall

A transcription error has occurred for the Randox Lipase colorimetric value in Liquid Clinical Chemistry Control lot 1021 UE. The target and range are listed as 50 U/L (40 - 60) and should be 72U/L (58 - 86).

Distribution pattern

US: NY and DE OUS: France, Lithuania, Poland, Spain, Switzerland, Turkey, Australia, Hong Kong, Bosnia and Herzegovina, Costa Rica, Ecuador, Gambia, New Zealand and Solomon Islands.

Code information

Catalogue Number: LAE4217 GTIN: 05055273208993 Lot Number: 1021UE (EXP: 2020-06-28)

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1100-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1100-2020. Report a data issue: hello@regdatalab.com.